CN Patent
CN104000821B — 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法
Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2020-06-19 · 6y expired
What this patent protects
本发明公开了一种含有替米沙坦和苯磺酸氨氯地平的口服双层片剂,其特征在于该片剂包含替米沙坦第一层和氨氯地平第二层,并且替米沙坦层采用顶喷制粒工艺。本发明提供的替米沙坦苯磺酸氨氯地平片片面美观,质量稳定。本发明还提供所述该口服片剂的制备方法,工艺简单,成本较低,更适合商业化生产。
USPTO Abstract
本发明公开了一种含有替米沙坦和苯磺酸氨氯地平的口服双层片剂,其特征在于该片剂包含替米沙坦第一层和氨氯地平第二层,并且替米沙坦层采用顶喷制粒工艺。本发明提供的替米沙坦苯磺酸氨氯地平片片面美观,质量稳定。本发明还提供所述该口服片剂的制备方法,工艺简单,成本较低,更适合商业化生产。
Drugs covered by this patent
- Zykadia (ceritinib) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.